Nephrotic Syndrome clinical trials at University of California Health

1 research study open to eligible people

Showing trials for

  • Belimumab With Rituximab for Primary Membranous Nephropathy

    open to eligible people ages 18-75

    The primary objective of this study is to evaluate the effectiveness of belimumab and intravenous rituximab co-administration at inducing a complete or partial remission (CR or PR) compared to rituximab alone in participants with primary membranous…

    at UCLA UCSF

Our lead scientists for Nephrotic Syndrome research studies include .

Last updated: